| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.70B | 32.70B | 33.42B | 29.91B | 30.64B | 26.51B |
| Gross Profit | 10.14B | 10.52B | 9.82B | 9.96B | 9.53B | 8.64B |
| EBITDA | 3.09B | 3.09B | 3.01B | 2.71B | 2.66B | 2.39B |
| Net Income | 895.92M | 960.03M | 888.73M | 733.71M | 660.79M | 755.39M |
Balance Sheet | ||||||
| Total Assets | 21.38B | 23.17B | 22.13B | 21.83B | 21.81B | 20.22B |
| Cash, Cash Equivalents and Short-Term Investments | 3.30B | 3.36B | 3.22B | 3.69B | 3.59B | 3.07B |
| Total Debt | 1.56B | 1.54B | 1.56B | 2.01B | 2.03B | 2.04B |
| Total Liabilities | 6.37B | 7.22B | 7.22B | 7.69B | 7.58B | 6.86B |
| Stockholders Equity | 15.01B | 15.95B | 14.91B | 14.13B | 13.80B | 13.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 334.27M | 667.22M | 810.80M | 1.13B | -568.08M |
| Operating Cash Flow | 0.00 | 2.73B | 2.02B | 2.28B | 2.26B | 1.06B |
| Investing Cash Flow | 0.00 | -2.27B | -1.67B | -1.45B | -1.49B | -2.25B |
| Financing Cash Flow | 0.00 | -338.38M | -858.37M | -980.63M | -290.59M | -530.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥107.71B | 15.19 | ― | 1.22% | -2.34% | -2.01% | |
73 Outperform | ¥14.17B | 15.18 | ― | 1.73% | -2.16% | 7.78% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | ¥287.08B | 11.01 | 20.44% | 3.28% | 4.21% | 30.94% | |
63 Neutral | ¥2.29T | 48.08 | 10.44% | 1.98% | 1.99% | 95.71% | |
63 Neutral | ¥2.21T | 10.29 | 11.05% | 1.53% | 7.51% | 232.54% | |
59 Neutral | ¥473.39B | 15.57 | 6.03% | 1.81% | -0.75% | 33.35% |